baber/WOPTO huggingface dataset:
Patent AU-2019201561-B2 (AU)
Title: UAV having hermetically sealed modularized compartments and fluid drain ports
Inventor: BELIK PAVEL
IPC: B64C35/00
Filed: 2019-03-06
Granted: 2021-03-25
Abstract: UAV HAVING HERMETICALLY SEALED MODULARIZED 
COMPARTMENTS AND FLUID DRAIN PORTS 
ABSTRACT 
An amphibious unmanned aerial vehicle (10) comprising: a) a fuselage (100) comprised of a 
buoyant material walls (110); b) separators (150,160) within the fuselage (100) forming separate 
compartments (120,130,140) within the fuselage (100); c) mounts (122,132r,132s,142) 
associated with the compartments (120,130,140) for securing waterproof aircraft components 
within the fuselage (100); and d) the compartments (120,130,140) each having drainage 
openings (128b) in the fuselage (100) extending from the interior of the fuselage (100) to the 
exterior of the fuselage (100).
Patent AU-2019204761-B2 (AU)
Title: Laundry treatment apparatus
Inventor: LEE JIHONG
IPC: D06F29/00
Filed: 2019-07-02
Granted: 2021-01-21
Abstract: A laundry treatment apparatus comprising: 
a cabinet having an opening; 
a drawer withdrawable from the cabinet through the opening; 
a tub provided in the drawer to store water; 
a drum rotatably provided in the tub to store laundry; 
a through hole provided in an upper surface of the drawer; 
a supply aperture provided in an upper surface of the tub; 
a fastening pipe mounted on the upper surface of the drawer; 
a first pipe connecting a water supply source with one end of the fastening pipe; and 
a second pipe connecting the supply aperture with the other end of the fastening pipe by 
being inserted into the through hole, 
wherein the second pipe is configured to be extensible from the upper surface of the 
drawer towards the upper surface of the tub.
[Figure 5] 
s 
35 
45 
. 89 2l 
73 
r' 353 
975a91 
K, 993 
- 973 313 
83 
K 3 
H 3 
8693 3 3 
883
Patent AU-2019219312-B2 (AU)
Title: C-kit antibodies
Inventor: FINLAY WILLIAM JAMES JONATHAN
IPC: C07K16/28
Filed: 2019-02-11
Granted: 2023-07-20
Abstract: Disclosed herein are antibody molecules binding specifically to C-KIT, antigen-binding portions thereof and medical uses therefor.
Patent AU-2019219473-B2 (AU)
Title: Skin-permeating carrier containing nucleic acid complex and use thereof
Inventor: KIM HYE JOO
IPC: A61K47/54
Filed: 2019-01-08
Granted: 2022-01-13
Abstract: The present invention relates to: a skin-permeating carrier containing a novel-structured nucleic acid complex for enabling a bioactive nucleic acid to be introduced into a cell; and a composition comprising same, for diagnosing, preventing or treating a disease. More specifically, the present invention relates to: a skin-permeating carrier exhibiting skin permeability and skin retention, and containing a nucleic acid complex having a bioactive nucleic acid complementarily bound with a carrier peptide nucleic acid; and a composition comprising same, for diagnosing, preventing or treating a disease. According to the present invention, the skin-permeating carrier containing the nucleic acid complex having a structure represented by structural formula (1) has, simultaneously,
Patent AU-2019271983-B2 (AU)
Title: Method of treating neurodegenerative disorders
Inventor: WEISER MICHAEL
IPC: A61K31/337
Filed: 2019-11-28
Granted: 2022-01-06
Abstract: The present disclosure is directed, at least in part, to disease-modifying treatments for 
neurodegenerative disorders. In one embodiment, a method of delaying worsening of one or 
more symptoms and/or progression of a neurodegenerative disorder is provided. In one 
5 embodiment, a method of treating or ameliorating one or more symptoms of a 
neurodegenerative disorder is provided. In one embodiment, the methods of the present 
invention comprise administering to a subject in need thereof, a compound having the 
structure of Formula (la): 
a 
H 
00 
OGOPh OAc 
OH Formula (la); and/or a pharmaceutically 
acceptable salt thereof. In one embodiment, the the compound of (la) and/or a 
10 pharmaceutically acceptable salt thereof is administered in combination with one or more 
pharmacologically active agents.
Patent AU-2019288048-B2 (AU)
Title: Combined medicine comprising gemcitabine-encapsulated liposome composition and immune checkpoint blockade
Inventor: KOMORI TAKASHI
IPC: A61P43/00
Filed: 2019-06-20
Granted: 2022-08-11
Abstract: The present invention addresses the problem of providing a medicine prepared by combining a liposome composition with an immune checkpoint blockade, wherein gemcitabine is encapsulated in a dissolved state in liposomes in the liposome composition. According to the present invention, a medicine which is a combination of (A) a liposome composition with (B) an immune checkpoint blockade is provided, wherein the liposome composition comprises liposomes each having an inner aqueous phase and an aqueous solution constituting an outer aqueous phase and having the liposomes dispersed therein, gemcitabine is encapsulated in a dissolved state in the liposomes, and the liposome composition and the immune checkpoint blockade are administered simultaneously or sequentially.
Patent AU-2019315800-B2 (AU)
Title: Medical handle
Inventor: CHU MICHAEL S H
IPC: A61B1/00
Filed: 2019-07-03
Granted: 2022-06-30
Abstract: A retrieval device attachable to a scope includes a handle which has an attachment portion configured to couple the handle to the scope; a shaft coupled to the handle having a wire immovably coupled to the handle; and a sheath movable relative to the handle over the wire between a distal position and a proximal position via an actuator of the handle. The actuator actuates a slider assembly of the handle. The slider assembly is coupled to the sheath and movable relative to the attachment portion to move the sheath and an expandable end effector coupled to the distal end of the wire. The end effector is movable between a collapsed configuration when the sheath is moved distally to the distal position to cover the end effector and an expanded configuration when the sheath is moved proximally to the proximal position, uncovering the end effector.
Patent AU-2019355946-B2 (AU)
Title: Slicing machines and methods for slicing products
Inventor: KING DANIEL WADE
IPC: B26D7/26
Filed: 2019-10-03
Granted: 2022-03-10
Abstract: Machines and methods for slicing products into lattice-type slices or chips. The methods and machines utilize a cutting head having an annular shape that defines an axis of the cutting head, and an impeller assembly coaxially mounted within the interior of the cutting head for rotation about the axis of the cutting head. The cutting head having at least one knife at a perimeter thereof and extending radially inward of the cutting head. The impeller assembly has a base, a cavity within the base, a central opening to the cavity within the base, and equi-angularly spaced tubular guides extending radially outward from the base for delivering products within the cavity toward the perimeter of the cutting head as the impeller assembly rotates within the cutting head. The impeller assembly includes features with the ability to increase product throughput and increase the useful lives of the impeller assembly and cutting head.
Patent AU-2019403411-B2 (AU)
Title: Integral magnet mount for golf ranging devices
Inventor: NYHART SCOTT O
IPC: G01C3/02
Filed: 2019-12-20
Granted: 2023-04-20
Abstract: A golf laser rangefinder comprises a housing with a pair of opposing side wall portions. One of the side wall portions has a magnetic attraction strip extending diagonally across the side wall portion for attachment to, for example, an upright roof support member of a golf cart. A display on the side wall portion opposite the magnetic attraction strip can provide data display, including real time data, to the driver or passenger of the golf cart when the laser rangefinder is mounted to the support member.
Patent AU-2020205213-B2 (AU)
Title: Use of derivatives of polyunsaturated fatty acids as medicaments
Inventor: ESCRIBA RUIZ PABLO VICENTE
IPC: A61K31/20
Filed: 2020-07-13
Granted: 2021-02-25
Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present 
invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of 
5 common diseases whose etiology is based on alterations (of any type) of the cell membrane 
lipids, for example, changes in levels, in the composition or in the structure of these lipids. In 
addition, for diseases in which the regulation of lipid composition and of the structure of the 
membranes (or proteins that interact with membranes) causes the reversion of pathological 
state.  
10
Patent AU-2020244556-B2 (AU)
Title: Controlled porosity devices for tissue treatments, methods of use, and methods of manufacture
Inventor: BACINO JOHN E
IPC: A61M25/10
Filed: 2020-10-01
Granted: 2022-04-07
Abstract: The invention is directed to a balloon comprising a porous membrane comprising a 
porous microstructure configured to inflate to a nominal diameter in response to 
introduction of a fluid at a first pressure, wherein the fluid begins to substantially 
perfuse through the balloon at a second pressure, the second pressure being at least 
equal to or greater than the first pressure, wherein the second pressure is at least 2 
atm.
6/15 
0708 
-- 706 
700 v',702 
701 
710 
715 
FIG. 7 
800 806 804 
FIG. 8
Patent AU-2020289888-B2 (AU)
Title: Guidewire navigation system with direct visualization feature
Inventor: MILLER SCOTT
IPC: A61M25/095
Filed: 2020-12-21
Granted: 2022-05-19
Abstract: Disclosed is a navigation system with a remote visualization element for navigating in remote 
spaces in medical and non-medical applications using multiple imaging modalities, including 
direct visualization.
Patent AU-2020294212-B2 (AU)
Title: De-immunized Shiga toxin A subunit effector polypeptides for applications in mammals
Inventor: POMA ERIC
IPC: C12N15/62
Filed: 2020-12-22
Granted: 2022-08-18
Abstract: The present invention relates to Shiga toxin effector polypeptides with 
reduced antigenic and/or immunogenic potential. Immunogenicity can be a 
limitation for the repeated administration to mammals of proteins and 
5 polypeptides derived from Shiga toxins. The Shiga toxin effector polypeptides of 
the present invention have uses as components of therapeutics, diagnostics, and 
immunization materials. The cytotoxic proteins of the present invention have 
uses for selective killing of specific cell types and as therapeutics for the 
treatment of a variety of diseases, including cancers, immune disorders, and 
10 microbial infections. The proteins of the present invention also have uses for 
detecting specific cell types, collecting diagnostic information, and monitoring 
the treatment of a variety of diseases, such as, e.g., cancers, immune disorders, 
and microbial infections.
Patent AU-2020344233-B2 (AU)
Title: Barbed microcatheters having fluid egress openings for infusing therapeutic fluids into tissue and methods of making and using the same
Inventor: CICHOCKI FRANK RICHARD JR
IPC: A61M25/01
Filed: 2020-09-02
Granted: 2024-01-04
Abstract: A microcatheter (100) for delivering therapeutic fluids to a patient, and methods of making and using the same. The barbed microcatheter includes a hollow tube (102) having an elongated lumen that extends between proximal and distal ends of the hollow tube, a plurality of barbs (108) projecting from the hollow tube, and a plurality of fluid egress openings (110) formed in the hollow tube that are in fluid communication with the elongated lumen. The fluid egress openings are evenly spaced from one another along the length of the hollow tube. An anchor (112) is secured to the proximal end of the hollow tube, and a surgical needle (114) is secured to the distal end of the hollow tube.
Patent AU-2021220242-B2 (AU)
Title: Roller mill with a synchronizing device
Inventor: GUERRERO PALMA PEDRO
IPC: B02C4/32
Filed: 2021-02-09
Granted: 2023-08-10
Abstract: The present invention relates to a roller mill (10) for comminuting bulk material, comprising a first milling roller (12) and a second milling roller (14), which are arranged so as to be opposite one another and which can be driven in a contra-rotating manner, wherein a milling gap (16) is formed between the milling rollers (12, 14), and a floating bearing unit (26) for receiving the first milling roller (12), and a fixed bearing unit (28) for receiving the second milling roller (14), wherein the floating bearing unit (26) has two bearings (34, 36) which each receive one end of the first milling roller (12), wherein the floating bearing unit (26) has mounted thereon a plurality of hydraulic actuators (38, 40) for applying a force to the floating bearing unit (26), and wherein the bearings (34, 36) of the floating bearing unit (26) are connected to one another by way of a synchronizing device (42), wherein the synchronizing device (42) has a coupling element (62, 64; 82) that prevents a relative movement of the bearings (34, 36) in a coupling position and allows a relative movement of the bearings (34, 36) in a free position.
Patent AU-2021269387-B2 (AU)
Title: Metal oxide cement
Inventor: WATERS TREVOR
IPC: C04B7/06
Filed: 2021-11-18
Granted: 2023-12-07
Abstract: A method for manufacturing a cement including: dissolving an organic binder 
that retains a naturally occurring silicate, by using a chemical activator; in 
5 association with a metal oxide; so that the silicate can participate in crystal 
growth, and the cement is a structural load bearing cement.
Patent JP-3911379-B2 (JP)
IPC: A61B8/06
Filed: 2000-03-08
Granted: 2007-05-09
Abstract: An ultrasonic diagnostic apparatus transmits ultrasonic waves at such a strength as to disperse the contrast agent for part of a number of sonic beams which form one frame and at such a strength as not to disperse the contrast agent for other sonic beams thereby to produce an image for a marking frame from received echo signals of ultrasonic transmission, and subsequently transmits ultrasonic waves successively at such a strength as not to disperse the contrast agent for all sonic beams thereby to produce images continuously for no-marking frames, and, after such a time length that the flow range is present within the view field, produces an image for another marking frame. These operations are repeated to display ultrasonic images by which it is possible to visually recognize at a glance the time-wise change of a blood flow.
Patent JP-4528417-B2 (JP)
IPC: A45D34/04
Filed: 2000-05-10
Granted: 2010-08-18
Abstract: The mascara brush consists of two sections of wire (3) twisted together, holding bristles (4). At least some of the bristles (4b) are formed as loops (5), while the remainder (4a) extend radially outwards in the conventional manner. The loops are twisted int each other, e.g. forming a figure 8. Sections with looped bristles alternate with sections with straight bristles.
Patent JP-4646275-B2 (JP)
IPC: C22C9/02
Filed: 2000-06-12
Granted: 2011-03-09
Abstract: Copper-based alloy contains (in wt.%): 4-12 tin, 0.1-4 iron, 0.01-0.6 titanium and a balance of copper.
Patent JP-4298150-B2 (JP)
IPC: B60K6/20
Filed: 2000-09-26
Granted: 2009-07-15
Abstract: A hybrid-vehicle drive unit supports a motor-generator with high precision, improving the efficiency of the motor-generator, and reducing the size of the motor-generator, independent of any influence of centering precision of the crank shaft and of deformation of the torque converter. According to the invention, a motor housing is disposed between a converter housing and an internal combustion engine, and a bearing is fitted to a lateral wall provided in a front portion of the motor housing. Rotor supporting members are independently supported by the bearing. Eccentric rotation of the crank shaft resulting from explosive vibrations of the engine is counteracted by two flex plates. Owing to a predetermined clearance, one of the rotor supporting members as a separate component is free from the influence of deformation of the torque converter.
Patent JP-4817494-B2 (JP)
IPC: C07K16/28
Filed: 1999-05-12
Granted: 2011-11-16
Abstract: The present invention encompasses methods and compositions useful in diagnosing and treating hepatic disorders, especially those characterized by inflammation. The method comprises administration of an agent which prevents the interaction of MAdCAM with a MAdCAM binding partner or ligand. These compositions are useful in treating diseases or disorders involving  alpha 4 beta 7/MAdCAM blockade, as well as inhibiting a primary event in the inflammatory response such as blocking interactions between intercellular adhesion molecules and their ligands. Disorders treatable using the methods disclosed herein include infections, especially viral infections, iatrogenic disorders, cholestatic disorders, hereditary disorders, sarcoidosis, organ transplant, and the like. The diagnostic methods of the invention can be employed to detect the presence of a disorder or to monitor the course of therapy used to treat the disorder.
Patent JP-4267206-B2 (JP)
IPC: A61M5/168
Filed: 1999-10-28
Granted: 2009-05-27
Abstract: Apparatus to connect a medication reservoir (1) to a pump housing (30) comprises a cap (4) connected to the medication reservoir to be secured into the pump housing a tab (36) formed on the top of the cap (4) so as to provide a surface for a user to grip and twist the cap to engage the cap, connected to the medication reservoir (1), with the pump housing (30); a raised portion of the cap having a cavity to secure to infusion set tubing; and an engagement member disposed on the cap (4) to engage a housing engagement member of the pump housing, wherein the cap connected to the medication reservoir (1) forms an integrated unit that is secured into the pump housing (30) when the engagement member disposed on the cap (4) is engaged with the housing engagement member.
Patent JP-3964622-B2 (JP)
IPC: C07K19/00
Filed: 2000-05-16
Granted: 2007-08-22
Abstract: Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more amino acids of positions 484-508 of the A2 domain. The modified factor VIII is useful as a clotting factor supplement for hemophiliacs.
Patent JP-4671509-B2 (JP)
IPC: A61Q17/04
Filed: 2000-05-24
Granted: 2011-04-20
Abstract: The present invention generally relates to safe and stable sunscreen compositions comprising of at least one sunscreen active ingredient in the form of an inert sol-gel microcapsules encapsulating ultraviolet absorbing compounds in any acceptable cosmetic vehicle. The composition according to the present invention can comprise several ultraviolet absorbers that may be encapsulated in the same sol-gel microcapsule or in different capsules. The encapsulation of the ultraviolet absorbers reduces or even prevents the contact between the sunscreen compounds and the human tissue, thus reducing various adverse effects that are associated with the use of sunscreens, such as photoallergy and phototoxicity, and makes the composition safer for use. The encapsulation also reduces or even prevents cross reactivity between the sunscreen compounds and the packaging material and between the sunscreen compounds and any other component present in the composition, thus enhance the compositions stability. The hydophobicity/hydrophilicity character of the sol-gel microcapsules can be controlled by selecting suitable sol-gel precursors and suitable reaction conditions and can be chosen to be compatible with the cosmetic vehicle to be used in the sunscreen composition, thus, the present invention facilitates an easy incorporation of the composite sol-gel encapsulated sunscreen in all types of cosmetic vehicles including oil free compositions, with no necessary steps of heating or high shear forces. The sunscreen compositions of the present invention can comprise any acceptable UVA and/or UVB absorbing compounds at any desired ratio to obtain a desired accumulative ultraviolet screening spectrum.
Patent JP-3672505-B2 (JP)
IPC: B01F25/60
Filed: 2001-06-19
Granted: 2005-07-20
Abstract: An underwater agitation pump can suck soil, sand or the like which contains block-like material or string-like material in a dredging site or the like while efficiently agitating such soil, sand or the like and thereafter can discharge such sand, soil or the like to a desired place. The underwater agitation pump 10 comprises an impeller casing 11 in which an impeller 15 driven by a motor 18 is rotatably accommodated, an agitated material suction guide cylinder 23 being constituted of a hollow cylinder which has proximal end opening portion thereof integrally communicably connected to a center suction opening portion 16 of the impeller 15 while passing through a center opening 12 of the impeller casing 11 and having the distal end opening portion thereof extended downwardly, the agitated material suction guide cylinder 23 further forming an agitated material suction passage 24 in the inside thereof, and an agitator 25 which is mounted on an outer peripheral portion of the distal end opening portion of the agitated material suction guide cylinder 23. Due to such a constitution, the agitated material suction passage 24 formed in the inside of the agitated material suction guide cylinder 23 can ensure a sufficiently wide agitated material inflow area. <IMAGE>
Patent JP-4060078-B2 (JP)
IPC: G01N27/327
Filed: 2000-05-31
Granted: 2008-03-12
Abstract: A disposable electrode strip for testing a fluid sample including a laminated strip with a first and second end, a reference electrode embedded in the laminated strip proximate to the first end, at least two working electrodes embedded in the laminated strip proximate to the first end and the reference electrode, an open path for receiving a fluid sample beginning from the first end and being sufficiently long to expose the reference electrode and the working electrodes to the fluid sample, and conductive contacts located at the second end of the laminated strip. The laminated strip has a base layer with a conductive coating, a reagent holding layer, a channel forming layer and a cover. One of the working electrodes contains a reagent substantially similar to the reagent of the reference electrode and a second working electrode contains a reagent having an enzyme.
Patent JP-4446325-B2 (JP)
IPC: F03D7/00
Filed: 2000-07-19
Granted: 2010-04-07
Abstract: A first capture unit includes a first turbine rotor having a first hub. A second capture unit includes a second turbine rotor having a second hub. The rotors counter-rotate independently. A first electric generator includes a first rotor fixed to the first turbine rotor and a first stator fixed so as to face the first rotor. A second electric generator includes a second rotor having a rotor fixed to the second turbine rotor and a second stator fixed so as to face the second rotor. Power electronic means control the electric currents produced by the first and the second stators of the first and the second electric generators independently of each other thus regulating the rotational speed of the first and second turbine rotors.
Patent JP-4488663-B2 (JP)
IPC: A61K31/415
Filed: 2000-09-08
Granted: 2010-06-23
Abstract: Invented are non-peptide TPO mimetics. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.